학술논문
Infection risk with immunomodulatory and proteasome inhibitor–based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysis
Document Type
Article
Source
In European Journal of Cancer November 2016 67:21-37
Subject
Language
ISSN
0959-8049